Aprepitant
These highlights do not include all the information needed to use APREPITANT CAPSULES safely and effectively. See full prescribing information for APREPITANT CAPSULES. APREPITANT capsules, for oral use Initial U.S. Approval: 2003
d72e0e10-4557-41b0-b65d-d395468cad19
HUMAN PRESCRIPTION DRUG LABEL
Jan 28, 2020
Glenmark Pharmaceuticals Inc., USA
DUNS: 130597813
Products 4
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
Aprepitant
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
Aprepitant
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (16)
Aprepitant
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (17)
Aprepitant
Product Details
FDA regulatory identification and product classification information